SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BBAI is trending due to high volume and a recent surge in price, sparking discussions around potential short squeezes and upcoming government contracts. The community is also buzzing about a congresswoman's recent stock purchase, fueling speculation of federal wins for the company. Overall, the stock's strong price action and unusual options activity are generating significant interest.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The memecoin "crow with knife" ($CAW.X) is gaining traction, with community members highlighting its fully circulated supply and multichain presence across Solana, BSC, Cronos, and Ethereum (Base). Recent mentions of Coinbase Wallet and other tier 1 listings have amplified community excitement, with many calling it the only option.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

LKNCY is trending as community members discuss the potential impact of Starbucks' China operations sale and the company's growing presence in the US market, especially New York City. Some investors express frustration with the stock's price stagnation and look forward to a potential relisting, while others highlight the company's strong growth metrics and expansion plans. There is also discussion around potential collaborations and competition within the coffee market.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending due to excitement surrounding its acquisition of Oxford Ionics and the formation of IonQ Federal, sparking bullish sentiment and analyst upgrades. Community discussions revolve around the potential for significant gains, comparisons to other high-growth stocks, and debates about its valuation. The broader context includes growing interest in the quantum computing sector and upcoming presentations at the Quantum World Congress.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital (MARA) is trending as traders discuss its potential correlation with Bitcoin's price movements and the upcoming Fed announcement, while some express concerns about potential share offerings. Community members are debating its valuation, short squeeze potential, and comparing it to other miners. Broader discussions include its position within the crypto mining sector and the impact of insider buying.

MicroAlgo, Inc. operates as a holding company, which engages in the development and application of bespoke central processing algorithms. Its services include algorithm optimization, accelerating computing power without the need for hardware upgrades, lightweight data processing, and data intelligence. The company was founded May 14, 2018 and is headquartered in New York, NY.

MicroAlgo Inc

MicroAlgo ($MLGO) is trending as day traders discuss its potential for a short squeeze and compare it to previous high-flying stocks. Community members are pointing to the low float and past rallies, while also debating dilution risks and potential for a crypto treasury announcement. Some traders are expressing skepticism, labeling it a "scam" stock while others are anticipating a significant upward move.

Turbo Energy SA provides energy solutions. It engages in the developing, manufacturing and distributing of photovoltaic products. The company was founded on September 18, 2013 and is headquartered in Valencia, Spain.

Turbo Energy S.A. - ADR

Turbo Energy (TURB) is trending due to news of a significant $53 million energy storage project in Spain, sparking a massive surge in price and volume. The community is actively discussing its low float and potential for continued upward momentum, drawing comparisons to other recent high-flying stocks. Some traders caution against chasing the rally and point to potential pullbacks.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending as the community discusses potential catalysts like the upcoming Meta Connect event and speculation around new AI integrations and smart glasses. Bullish sentiment seems to be fueled by Zuckerberg's pledge to invest heavily in AI infrastructure. Some traders are actively trading options, while others debate whether the stock is overvalued.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending as investors discuss its potential in the quantum computing sector, drawing comparisons to IONQ and QBTS. Community members are actively trading options, anticipating a breakout and a potential short squeeze. Some see the stock as a long-term play, while others are wary of near-term volatility and possible pullbacks.

FGI Industries Ltd. engages in the supply of kitchen and bath products. Its products fall under the following categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The Sanitaryware category offers bath products such as toilets, sinks, pedestals and toilet seats. The Bath Furniture category deals with wood and wood-substitute furniture for bathrooms, including vanities, mirrors, laundry and medicine cabinets, and other storage systems. The Shower Systems category includes a range of shower-related products such as shower walls, shower doors and shower basins. The Others category includes shower door and shower systems products, custom kitchen cabinetry, and other accessory items. The company was founded on May 26, 2021 and is headquartered in East Hanover, NJ.

FGI Industries Ltd

FGI is experiencing significant volatility and upward momentum, with community members discussing a potential short squeeze and a possible ride to much higher prices. Traders are pointing to the stock's low float and substantial trading volume as key factors driving the intense interest. Some are comparing it to other recent high-flying low floaters, while others cite the company's strong fundamentals and growth potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MRK, Daiichi's ADC Drug Gets FDA Breakthrough Tag for Ovarian Cancer

Merck and Daiichi's raludotatug deruxtecan wins FDA Breakthrough tag for treating CDH6 expressing platinum-resistant ovarian, primary peritoneal or fallopian tube cancers.

Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?

The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects

Pfizer's late-stage pipeline, from oncology blockbusters to mRNA vaccines, positions it for long-term growth despite recent setbacks.

BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?

Bristol Myers and BioNTech report strong mid-stage lung cancer trial data for pumitamig, showing high response rates and manageable safety.

Merck (MRK) Outpaces Stock Market Gains: What You Should Know

Merck (MRK) concluded the recent trading session at $85.11, signifying a +1.28% move from its prior day's close.

Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock?

Merck stock is down 14% this year as Keytruda-led growth gets offset by Gardasil weakness and looming patent risks, which cloud the outlook.

Bristol Myers Loses 19.2% in Six Months: Buy, Sell or Hold? 

Bristol Myers struggles with falling shares and legacy drug headwinds, but growth drugs and new approvals help steady revenues.

U.S. stocks closed Wednesday’s session mixed, with the broader S&amp;P 500 Index and the Nasdaq Composite hitting fresh highs, while the Dow Jones Industrial Average retreated.Although the tame producer price inflation report generated some strength in the market in the morning session, the perils of trading an overbought market made traders cautious as the session progressed.The following stocks saw the biggest volume surge in extended trading, even as the market turns its attention to the August consumer price inflation CPI) report due on Thursday:SLB Ltd. (SLB)After-hours move: 0.14%Trading volume: 5.86 millionOilfield services company SLB remained on investors’ radar despite the lack of any significant news. The Houston, Texas-based company’s shares rose over 1% on Wednesday, outperforming the broader market, after crude oil futures climbed 1.7% during the session.&nbsp;The stock, however, is down 3.5% for the year-to-date period.<figure class="image"><img style="aspect-ratio:618/54;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_12_40_24_AM_png_ff671b9818.webp" alt="Screenshot 2025-09-11 at 12.40.24 AM.png" width="618" height="54"><figcaption>SLB sentiment and message volume as of 12:40 a.m. ET, Sept. 11 | source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/SLB">SLB stock</a> remained ‘neutral’ (51/100) by late Wednesday, and the message volume also stayed ‘normal.’Apple, Inc. (APPL)After-hours move: +0.10%Trading volume: 4.67 millionApple’s stock tumbled over 3% on Wednesday, even as the broader market managed to close in the green. The drop came despite the stock snagging a slew of price target hikes from Wall Street firms following the “Awe Dropping” hardware launch event held on Tuesday.BofA, Rosenblatt, Melius Research and Evercore ISI were among the firms that upped their price targets for Apple’s stock, with the updated estimates from these firms ranging from $241 to $290, the Fly reported. JPMorgan and Citi said the launch event was aligned with their expectations, while Morgan Stanley said it was slightly more awe-dropping than expectations.<a href="https://stocktwits.com/symbol/AAPL">Apple stock</a> is down about 9.1% year-to-date (YTD).<figure class="image"><img style="aspect-ratio:615/58;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_12_42_11_AM_png_38eba34d1f.webp" alt="Screenshot 2025-09-11 at 12.42.11 AM.png" width="615" height="58"><figcaption>AAPL sentiment and message volume as of 12:40 a.m. ET, Sept. 11 | source: Stocktwits</figcaption></figure>Retail sentiment toward the stock remained ‘extremely bullish’ (85/100), and the message volume was ‘extremely high.’&nbsp;Nvidia Corp. (NVDA)After-hours move: -0.10%Trading volume: 4.21 millionNvidia rode on the back of Oracle's (ORCL) exuberance and ended Wednesday’s session up nearly 5% at $177.33, although it was off its all-time intraday high of $184.48. However, retail interest is on the wane. On Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/NVDA">Nvidia stock</a> remained ‘bearish’ (37/100). The message volume on the stream was ‘low’ relative to historical norms.<figure class="image"><img style="aspect-ratio:622/59;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_12_43_57_AM_png_ec461b54d9.webp" alt="Screenshot 2025-09-11 at 12.43.57 AM.png" width="622" height="59"><figcaption>NVDA sentiment and message volume as of 12:40 a.m. ET, Sept. 11 | source: Stocktwits</figcaption></figure>The shares of the artificial intelligence chipmaker are up more than 32% this year.Merck &amp; Co. (MRK)After-hours move: +0.10%Trading volume: 3.91 millionPharma giant Merck has come onto investors’ radar as it declined on Wednesday, aligning with the pullback in the healthcare stocks in the afternoon. The S&amp;P 500 Healthcare Index fell 0.91% on Wednesday.The company also abandoned plans to build a research center in the U.K., citing the “challenges of the UK not making meaningful progress towards addressing the lack of investment in the life science industry and the overall undervaluation of innovative medicines and vaccines by successive UK governments,” the London Times&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.thetimes.com/business-money/companies/article/merck-attacks-uk-life-sciences-investment-scraps-1bn-hq-jbzz9nmnb">reported.</a><figure class="image"><img style="aspect-ratio:620/50;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_12_45_04_AM_png_6aeae81193.webp" alt="Screenshot 2025-09-11 at 12.45.04 AM.png" width="620" height="50"><figcaption>MRK sentiment and message volume as of 12:40 a.m. ET, Sept. 11 | source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/MRK">Merck stock</a>, which has fallen nearly 14% this year, elicited ‘bearish’ sentiment (42/100) from among users on Stocktwits. The message volume was at ‘normal’ levels.Gilead Sciences, Inc. (GILD)After-hours move: +0.65%Trading volume: 3.57 millionGildead Sciences was in the news on Wednesday as RBC Capital Markets named the company as one of the beneficiaries of Health and Human Services (HHS) Secretary and prominent antivaxxer Robert Kennedy's potential departure from the agency.&nbsp;The firm said healthcare could be viewed as "less unpredictable" and "more investable" if the secretary were to depart his position, according to the Fly.Kennedy has been under pressure from HHS employees, both former and current, to quit, as they alleged that he has put the health of America at risk with his actions, which include cancelling emergency use authorizations for COVID-19 vaccines without providing data or methods to justify the decision.<figure class="image"><img style="aspect-ratio:616/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_12_46_18_AM_png_9b7d1d480e.webp" alt="Screenshot 2025-09-11 at 12.46.18 AM.png" width="616" height="53"><figcaption>GILD sentiment and message volume as of 12:40 a.m. ET, Sept. 11 | source: Stocktwits</figcaption></figure>Retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/GILD">Gilead Sciences stock</a> remained ‘neutral’ (47/100). and the message volume also stayed at ‘normal’ levels.The stock has gained 26.5% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/goldman-sachs-ceo-sees-25-bps-fed-rate-cut-as-done-deal/chwN5NiRdH4">Will Fed Cut Rates Next Week? What Goldman Sachs CEO David Solomon Predicts For September Meeting And Rest Of 2025</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on July 30, 2025, in New York City. 

SLB, Apple, Nvidia, Merck, Gilead Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks?

Two stocks, each from the tech and healthcare sectors, experienced brisk trading activity in the post-market session on Wednesday, although volumes were relatively muted.

Equity

Two stocks, each from the tech and healthcare sectors, experienced brisk trading activity in the post-market session on Wednesday, although volumes were relatively muted.


Merck (MRK) has reportedly scrapped a £1 billion ($1.35 billion) London research centre and intends to lay off over 100 scientific staff in the U.K.The Financial Times <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/5ace49a8-47ab-409d-8909-6edb107ce71a">reported </a>on Wednesday that the drugmaker scrapped the research centre in King’s Cross, which was due to open in 2027, and instead would move research activity to existing sites, predominantly in the U.S. The company committed to the research centre focused on neuroscience, inflammation, and immunology in King’s Cross in 2017, and construction commenced in 2023, FT said.Merck would also lay off 125 scientists and support staff who had been working on early discovery efforts at the Francis Crick Institute and the London Bioscience Innovation Centre, according to the report.However, the company will continue to run clinical trials in the country and will have about 1,600 staff working on these development programs and other areas, the report said. Merck told FT in a statement that the U.K. is “not internationally competitive.”The decision comes on the heels of a battle between drug makers and the U.K. Health Secretary Wes Streeting on medicine prices. However, Merck told FT that its decision to scrap the London research centre was not related to the drug-pricing negotiations with the government.The company, however, stated that the U.K. would lag behind its European peers in the share of the health budget allocated to drugs unless it improved its ability to attract and retain investment, according to the FT.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/MRK">MRK stock</a> fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels.<figure class="image"><img style="aspect-ratio:625/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_10_at_12_15_49_PM_png_73cef3623f.webp" alt="MRK's Sentiment Meter and Message Volume as of 12:16 p.m. ET on Sept. 10, 2025 | Source: Stocktwits" width="625" height="62"><figcaption>MRK's Sentiment Meter and Message Volume as of 12:16 p.m. ET on Sept. 10, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expects the stock to reach $97.50, implying a reasonable upside from its current trading levels.<stembedurl>https://stocktwits.com/wilpd/message/628089752</stembedurl>Meanwhile, in the United States, Merck <a href="https://stocktwits.com/news-articles/markets/equity/trump-to-issue-60-day-warning-letters-to-drugmakers-over-pricing/choL0IMRdGB">faces</a> a September-end deadline to reduce the cost of its medicines as Trump pushes drugmakers to lower the cost of drugs in the U.S. to the levels paid by other developed nations.According to data from Koyfin, 15 of the 37 analysts covering Merck rate it ‘Buy’ or higher, while 12 rate it ‘Hold’. The average price target for the stock is $102.33, representing an upside of over 22%.MRK stock is down by 16% this year and by 27% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wells-fargo-analyst-expects-tesla-q3-deliveries-to-fall-below-consensus-estimate/chwkig8RduAhttps://stocktwits.com/news-articles/markets/equity/wells-fargo-analyst-expects-tesla-q3-deliveries-to-fall-below-consensus-estimate/chwkig8RduA">This Analyst Expects Tesla Q3 Deliveries To Fall Below Consensus Estimates: Retail Sees Rally To $400 After Next Earnings</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on November 5, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Merck Reportedly Scraps Research Centre In UK: Retail Sees Stock Rallying To $97.50 

The Financial Times reported on Wednesday that the drugmaker scrapped the research centre in King’s Cross, which was due to open in 2027, and will instead move research activity to existing sites. 

J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum

J&J secures FDA approval for Inlexzoh, which boosts its Innovative Medicine pipeline and reinforces long-term growth momentum.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

Current Price	$81.09
Prev Close	$81.02
Open	$81.01
Dividend Yield	3.14%
50-Day Moving Average	$82.85
Beta	0.29
Avg. Volume	10.98M
PE Ratio	12.49

52-Week High	$119.38
52-Week Low	$73.31
Market Capitalization	$202.37B
EPS (Annual)	$6.74
Price to Book	4.14
Revenue Per Employee	$852,973.33
Enterprise Value/EBITDA	N/A

MRK
Merck & Co Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MRK News

MRK Merck & Co Inc